v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net loss $ (43,008) $ (50,243)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization 2,952 3,570
Impairment of intangible assets 3,027
Impairment of operating lease right-of-use assets 393
Unrealized gain on derivative liability (2,794)
Unrealized gain on warrant liability (2,564)
Loss on debt extinguishment 4,654
Inventory write-downs 48
Non-cash interest expense 7,325
Amortization of debt discount and issuance costs on notes payable 7,723
Share-based compensation expense 3,851 7,096
Net accretion of premium on short-term investments (195) (535)
Change in:    
Accounts receivable 822 (1,021)
Inventory (3,796) (410)
Other current and non-current assets (210) 1,818
Accounts payable 432 (850)
Accrued liabilities (275) 254
Contract liabilities and other current liabilities (450) (765)
Operating lease liabilities (1,097) (1,299)
Other long-term liabilities (197) (476)
Net cash used in operating activities (26,827) (39,393)
Cash flows from investing activities    
Sales of investment securities 22,402 22,655
Purchases of investment securities (19,326) (23,488)
Purchases of property and equipment (307) (280)
Cash paid for Ibeo business combination (6,300)
Net cash provided by (used in) investing activities 2,769 (7,413)
Cash flows from financing activities    
Principal payments under finance leases (6)
Proceeds from stock option exercises 62
Net proceeds from issuance of common stock and warrants 43,289 26,109
Net cash provided by financing activities 43,283 26,171
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 319 26
Change in cash, cash equivalents, and restricted cash 19,544 (20,609)
Cash, cash equivalents, and restricted cash at beginning of period 56,247 49,391
Cash, cash equivalents, and restricted cash at end of period 75,791 28,782
Supplemental schedule of non-cash investing and financing activities    
Common stock issued in conversions of notes payable 21,980
Issuance of warrants 6,297
Acquisition of right-of-use asset 67
Accrued financing fees 10
Foreign currency translation adjustment 540 (64)
Unrealized loss on investment securities, available-for-sale $ (22) $ (45)

Source

HTML PDF
ZIP